TXMD
TherapeuticsMD Inc
Price:  
1.25 
USD
Volume:  
14,935.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TXMD WACC - Weighted Average Cost of Capital

The WACC of TherapeuticsMD Inc (TXMD) is 5.3%.

The Cost of Equity of TherapeuticsMD Inc (TXMD) is 6.95%.
The Cost of Debt of TherapeuticsMD Inc (TXMD) is 5.00%.

Range Selected
Cost of equity 5.70% - 8.20% 6.95%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.7% - 5.9% 5.3%
WACC

TXMD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.4 0.6
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.70% 8.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.7% 5.9%
Selected WACC 5.3%